COMMUNIQUÉS West-GlobeNewswire

Medtech specialist Acarix AB names Christian Lindholm as Interim CEO
23/02/2018
Press release Malmö, February 23, 2018 Medtech specialist Acarix AB names Christian Lindholm as Interim CEO Acarix AB (publ) ("Acarix"), developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment [...]
Montebello to distribute Biohit products in Norway
23/02/2018
Biohit Oyj Press release, February 23rd, 2018 at 10:00 a.m. local time (EET) Biohit Oyj and Montebello Diagnostics AS have signed an agreement for the distribution of Biohit diagnostic products in Norway. The contract [...]
Aino Health AB (publ): publishes Year-end Report October - December 2017
23/02/2018
Aino Health AB (publ) has published its Year-end Report for the period, 1 October - 31 December 2017 today. It is available on the Aino Health website, see also attached pdf-document. Significant events - Business [...]
Notice for the Annual General Meeting of Novo Nordisk A/S
23/02/2018
Bagsværd, Denmark, 23 February 2018 - The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 22 March 2018 at 2.00 pm (CET) at Royal Arena, entrance G, Hannemanns Allé 20, 2300 Copenhagen S, Denmark. [...]
FDA Accepts Shire's BLA and Grants Priority Review for Lanadelumab for the Prevention of Attacks in HAE Patients
23/02/2018
FDA Accepts Shire's Biologics License Application (BLA) and Grants Priority Review for Lanadelumab for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients - Lanadelumab, the first long-acting [...]
Basilea reports clinical phase 3 study start with antibiotic ceftobiprole in skin infections under BARDA contract
23/02/2018
Basel, Switzerland, February 23, 2018 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has commenced enrollment in the first of its two planned clinical phase 3 registration studies of the antibiotic [...]
Addex Publishes Extraordinary General Meeting Invitation
23/02/2018
Geneva, Switzerland, 23 February 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that it has published the Invitation to its [...]
Dova Pharmaceuticals, Inc. Announces Pricing of Offering of Common Stock
23/02/2018
DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for rare diseases where there is [...]
Chembio Diagnostics to Report Fourth Quarter and 2017 Financial Results on March 8, 2018
22/02/2018
MEDFORD, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for [...]
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress
22/02/2018
SAN DIEGO, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering [...]
Helix BioPharma Corp. Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities
22/02/2018
RICHMOND HILL, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP ) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates [...]
Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results
22/02/2018
Reaffirms full year 2018 forecast and 2020 goals Revises 1Q 2018 forecast GAITHERSBURG, Md., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) reported financial results for the quarter and [...]
Harvard Bioscience Schedules Fourth Quarter 2017 Conference Call for March 1 at 4:30 PM ET
22/02/2018
HOLLISTON, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results [...]
Arbutus Settles Litigation, Terminating Acuitas’ Rights to LNP Technology
22/02/2018
Acuitas has No Further Rights to Use or Sublicense Arbutus LNP Technology Arbutus Consolidates LNP Patent Estate Enabling RNAi, mRNA, and Gene-editing Therapeutics VANCOUVER, B.C. and WARMINSTER, Pa., Feb. 22, 2018 ( [...]
Emisphere Development Update
22/02/2018
ROSELAND, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Novo Nordisk announced today the successful completion of the first phase 3a trial, PIONEER 1, with oral semaglutide, a once-daily oral formulation of the long-acting [...]
SteraMist™ Makes a Big Difference in Efforts to Fight the Flu in a Delaware Hospital
22/02/2018
BEVERLY HILLS, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) is a global company that specializes in plasma science based disinfection/decontamination using its [...]
Cytori to Webcast Fourth Quarter Financial Results on March 8th
22/02/2018
SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX ) will provide a live webcast of its fourth quarter financial results and business update on Thursday, March 8, 2018 at 5:30 PM [...]
BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results
22/02/2018
Company Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations MALVERN, Pa., Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ), the leading mobile and wireless medical technology company [...]
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2017 Financial Results
22/02/2018
MENLO PARK, Calif., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) will announce its financial results for the fourth quarter and year ended December 31, 2017, on Friday, March 16, 2018, after the [...]

Pages